VVUS Stock UPDATES Vivus Inc (VVUS) 4.29 09/02/2014 02:48:45

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vivus Inc (VVUS) 4.29 $VVUS

3 Simple Ways to Invest Like George Soros
George Budwell, The Motley Fool - Motley Fool - Sat Aug 30, 10:42AM CDT
Source: Wikimedia commons Before investing a single penny, you should have some type of overarching strategy or philosophy as a guide. Most commonly, the average investor turns to Warren Buffett in the hope of cracking Wall Street's secret code....

VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 4:00PM CDT
VIVUS, Inc. (VVUS) announced that it has acquired certain patents related to Topamax from Janssen Pharmaceuticals, Inc.

VIVUS buys topiramate-related patents from Janssen Pharmaceuticals
M2 - Tue Aug 26, 7:47AM CDT
Biopharmaceutical company VIVUS (NasdaqGS:VVUS) revealed on Monday the completion of the acquisition of a group of patents from Janssen Pharmaceuticals.

Vivus acquires patent rights to Qsymia ingredient
AP - Mon Aug 25, 7:37AM CDT
MOUNTAIN VIEW, Calif. (AP) — Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.

VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals
Marketwire - Mon Aug 25, 6:00AM CDT
VIVUS, Inc. (NASDAQ: VVUS) today announced the acquisition of a group of patents from Janssen Pharmaceuticals, Inc. covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions.

Biotech Investing: 3 Ways You're Doing It Wrong
Sean Williams, The Motley Fool - Motley Fool - Sun Aug 24, 1:35PM CDT
Source: Felixioncool , Pixabay When it comes to industries that offer investors a higher than average risk-versus-reward scenario, biotech investing arguably takes the cake. Since the benchmark S&P 500 bottomed out in March 2009 the index...

Auxilium Posts Wider-than-Expected Loss, Outlook Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 1:10PM CDT
The share price of Auxilium Pharmaceuticals, Inc. (AUXL) fell 9.6% after the company announced its second-quarter results on Aug 7. However, share prices have however recovered approximately 3.1% thereafter.

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 10:00AM CDT
VIVUS Inc. (VVUS) reported second quarter 2014 loss (excluding one-time items) of 25 cents per share.

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 8:20AM CDT
Orexigen Therapeutics, Inc. (OREX) reported a net loss of 21 cents per share in the second quarter of 2014.

VIVUS Reports Second Quarter 2014 Financial Results
Marketwire - Fri Aug 08, 5:25AM CDT
VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update.

Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 4:45PM CDT
Emergent BioSolutions (EBS) is set to report second quarter 2014 results on Aug 7 after the market closes.

Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 4:00PM CDT
Horizon Pharma (HZNP) is set to report second quarter 2014 results on Aug 7 before the market opens.

Will Mylan (MYL) Earnings in Q2 Disappoint Expectations? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 3:35PM CDT
Mylan (MYL) is set to report second quarter 2014 results on Aug 7 before the market opens.

Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma
PR Newswire - Wed Aug 06, 8:10AM CDT
On Tuesday, August 5, 2014, the NASDAQ Composite ended at 4,352.84, down 0.71%, the Dow Jones Industrial Average declined 0.84%, to finish the day at 16,429.47, and the S&P 500 closed at 1,920.21, down 0.97%. The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health care Sector Index ended the day at 701.26, down 0.89%, while the index has advanced 4.26% in the previous three months. Investor-Edge has initiated coverage on the following equities: Mylan Inc. (NASDAQ: MYL), AVANIR Pharmaceuticals Inc. (NASDAQ: ANVR), Horizon Pharma Inc. (NASDAQ: HZNP), VIVUS Inc. (NASDAQ: VVUS), and Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). Free research on these five companies can be accessed at:

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 10:10AM CDT
Arena Pharmaceuticals, Inc. (ARNA) reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014.

VIVUS Announces Date of Second Quarter 2014 Update and Financial Results Conference Call
GlobeNewswire - Thu Jul 31, 6:00AM CDT
VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results for the second quarter ended June 30, 2014 after the NASDAQ Market closes on Thursday, August 7, 2014. The company will conduct a conference call and an audio webcast at 4:30pm EDT the same day.

Vivus Shares Down 40.9% Since SmarTrend's Sell Call (VVUS)
Comtex SmarTrend(R) - Wed Jul 30, 4:44PM CDT
SmarTrend identified a Downtrend for Vivus (NASDAQ:VVUS) on January 22nd, 2014 at $8.65. In approximately 6 months, Vivus has returned 40.89% as of today's recent price of $5.11.

The Implications of Obesity as a Disability in Europe
Todd Campbell, The Motley Fool - Motley Fool - Sat Jul 19, 3:13PM CDT
If Europe's top court follows the advice of a key advisor, it may soon label severe obesity as a disability. If it does, pressure may increase in the European Union to approve drugs designed to reduce weight, including compounds developed by Arena...

Jim Cramer's 'Mad Money' Recap: High Hopes and Low-Expectation Stocks
at The Street - Tue Jul 15, 7:00PM CDT
Stick with companies where any good news will be met with big gains, Cramer says.

'Mad Money' Lightning Round: I Believe in Rite Aid
at The Street - Wed Jul 16, 5:00AM CDT
Cramer isn't buying Akamai Technologies, prefers Travelers over Chubb and wants General Electric to provide some answers.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 157

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
HashKey and Base Aim to Bridge Asia With Liquidity

Updated Category News Views 79

A blockchain partnership can sound like confetti until the plumbing matters. This one at least points at a real commercial choke point: Asian-originated tokenized assets need deeper pools of global onchain capital, while global networks need credible asset supply and institutional access. HashKey Group's HSK Chain and Coinbase-built Base say they intend to tackle both...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 91

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 227

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 127

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 25

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 159

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 42

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 182

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading

Top 5 Most Recently Viewed Articles

TRUBAR Inc. Takes Bold Steps with Personal Care Product Sale

Updated Category News Views 169

TRUBAR Inc. Streamlines Focus with Recent Asset Sale TRUBAR Inc. is making significant moves to streamline its operations and focus on its core identity as a leading provider of plant-based protein products. The company has announced that it has successfully sold the assets related to its personal care product line through its subsidiary, NO BS Life, LLC. This strategic...

Continue Reading
Advancements in Squamous Cell Carcinoma Treatments Unveiled

Updated Category News Views 362

Examining Treatments for Squamous Cell Carcinoma The landscape of squamous cell carcinoma (SCC) treatments is rapidly evolving. This shift is largely driven by the increasing number of diagnosed cases. As public awareness rises and exposure to risk factors like ultraviolet (UV) radiation continues, healthcare professionals and researchers are persistently seeking...

Continue Reading
Millennium Physician Group and IMA Medical Group Unite for Better Care

Updated Category News Views 327

Millennium Physician Group and IMA Medical Group Unite for Better Patient Care In an exciting development for healthcare in Central Florida, Millennium Physician Group has announced its collaboration with IMA Medical Group. This partnership represents a major step forward in expanding value-based, patient-centered care to the local communities. About the New Partnership...

Continue Reading
Innovative Partnership to Revolutionize Osteoporosis Detection

Updated Category News Views 96

Strategic Alliance to Enhance Osteoporosis Awareness Naitive Technologies Ltd., a leader in population health innovation focused on musculoskeletal care, has embarked on an important partnership with Parvizi Surgical Innovation (PSI). This collaboration aims to significantly improve the detection and clinical management of osteoporosis, particularly through the use of...

Continue Reading
Storm and Fire Survivors Unite at U.S. Capitol for Aid

Updated Category News Views 451

Storm and Fire Survivors Unite at U.S. Capitol for Aid Recently, over fifty storm and fire survivors convened at the U.S. Capitol to advocate for robust disaster relief and a more effective recovery system for affected families and communities, in an event organized by Organizing Resilience. These brave individuals came together to share their compelling stories,...

Continue Reading